Search peptides, terms, sources/
Regulatory source · 2013

Determination That GEREF (Sermorelin Acetate) Injection Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

About this source

Kind
Regulatory or official document
Design
Regulatory / legislative document
Primary or secondary
primary
Retraction status
None known
Date checked
13 August 2026

Limitations

US-only regulatory record; not controlling for UK status; cited for historical and comparative context only. Docket No. FDA-2012-P-1071.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.